microRNA-107 functions as a candidate tumor suppressor gene in renal clear cell carcinoma involving multiple genes

Nan Song1, Xin Ma1, Hongzhao Li1

  • 1Department of Urology, Chinese PLA General Hospital, Beijing, China.

Urologic Oncology
|March 12, 2015
PubMed
Abstract

Insights

MicroRNA-107 (miR-107) suppresses clear cell renal cell carcinoma by inhibiting cell proliferation and invasion. This finding offers a potential therapeutic strategy for renal cell carcinoma treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MicroRNAs (miRNAs) are small non-coding RNAs regulating gene expression.
  • miRNAs play dual roles as oncogenes or tumor suppressors in cancer.
  • Dysregulation of miRNAs is implicated in tumorigenesis and cancer progression.

Purpose of the Study:

  • To investigate the role of microRNA-107 (miR-107) in clear cell renal cell carcinoma (ccRCC).
  • To explore the potential of miR-107 as a therapeutic agent for ccRCC.

Main Methods:

  • Analysis of miR-107 expression in 52 paired clinical ccRCC specimens and cell lines.
  • Overexpression of miR-107 using lentiviral vectors and biosynthesis mimics in vitro and in vivo.
  • Assessment of cell proliferation, invasion, cell cycle, and tumor growth.
  • Identification of direct miR-107 targets using molecular assays.

Main Results:

  • miR-107 exhibited tumor-suppressing functions in ccRCC.
  • miR-107 overexpression inhibited proliferation and invasiveness of ccRCC cells (786-O).
  • High miR-107 levels induced G2/M phase cell cycle arrest and retarded tumor growth in vivo.
  • Eukaryotic translation initiation factor 5 was identified as a direct target of miR-107.
  • miR-107 expression was associated with p53 and VHL genes in ccRCC.

Conclusions:

  • miR-107 acts as a tumor suppressor in ccRCC by inhibiting cell proliferation and invasiveness.
  • miR-107 holds potential as a therapeutic target for ccRCC treatment.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.9K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.4K
MicroRNAs01:22

MicroRNAs

12.1K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
5.0K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K